Clover Health Stock (CLOV): $3.50 Price Target From Citi

By Amit Chowdhry ● Jan 10, 2022
  • The shares of Clover Health Investments Corp (NASDAQ: CLOV) have received a $3.50 price target from Citi. These are the details.

The shares of Clover Health Investments Corp (NASDAQ: CLOV) have received a $3.50 price target from Citi. And Citi analyst Jason Cassorla assumed coverage of Clover Health with a “Neutral” rating while reducing the price target from $9.

Cassorla had assumed coverage of the healthcare services space with a cautious but generally optimistic view. And while the backdrop remains fluid, the playing field has shifted as we enter 2022 with greater vaccine uptake and a relatively milder variant compared to 2021.

Plus Cassorla noted that amid the backdrop, he sees 3 major themes/debates driving the sector, including COVID-19 rollover and normalization of underlying core trends, inflationary cost pressures and offsets, and the reversion of focus back to structural shifts underpinning the healthcare industry.

Disclaimer: This content is intended for informational purposes. Before making any investment, you should do your own analysis.